StockData
Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc. (UNCY) stock

UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$3.70+0.00 (0.00%)

Close on Nov 17, 2026Market cap $103.06MP/E –Yield –

Unicycive Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Unicycive Therapeutics's profit margin for the twelve months ending Dec 31, 2023 was -4525.0%. For fiscal 2023 it was -4525.0%, against -1898.8% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-4525.0%−2626.2
FY2022Dec 31, 2022-1898.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2023Mar 31, 2023-2159.3%–
Q3 FY2022Sep 30, 2022-584.3%–

More Unicycive Therapeutics figures

See a number that looks wrong?